Lupin Limited has launched the Olmesartan Medoxomil tablets, 5 mg, 20 mg, and 40 mg, after receiving an approval from the US FDA. These tablets are the AB-rated generic equivalent of Daiichi Sankyo's Benicar tablets, indicated for the treatment of hypertension, alone or in combination with other antihypertensive agents, to lower blood pressure.


Digital version